ClinConnect ClinConnect Logo
Search / Trial NCT06888986

Integration of VR and AR Dementia Prevention Health Education Progrom for Older Adults with Mild Cognitive Impairment

Launched by NATIONAL TAIWAN NORMAL UNIVERSITY · Mar 15, 2025

Trial Information

Current as of April 29, 2025

Enrolling by invitation

Keywords

ClinConnect Summary

This study is a randomized controlled trial (RCT) designed to assess the effectiveness of a Virtual Reality (VR)-based cognitive health education program for older adults in Taiwan who exhibit signs of mild cognitive impairment (MCI). The study aims to determine whether VR-enhanced dementia prevention education improves dementia-related knowledge, health literacy, self-efficacy, and acceptance of dementia compared to a control group receiving standard health education without VR exposure and intervention.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adults aged 65 years or older.
  • AD-8 score ≥ 2, indicating potential cognitive impairment.
  • Able to understand and follow basic instructions in Mandarin or Taiwanese.
  • Capable of providing informed consent or has a legally authorized representative to provide consent.
  • Able to tolerate and interact with VR equipment (e.g., wearing a VR headset, using hand controllers).
  • Exclusion Criteria:
  • Diagnosed with moderate to severe dementia (i.e., unable to follow basic instructions).
  • Presence of severe visual, auditory, or motor impairments that prevent interaction with VR devices.
  • Diagnosed with severe psychiatric disorders (e.g., schizophrenia, major depressive disorder).
  • Unable to communicate effectively in Mandarin or Taiwanese.

About National Taiwan Normal University

National Taiwan Normal University (NTNU) is a prestigious institution dedicated to advancing education and research across various disciplines, including health sciences. As a clinical trial sponsor, NTNU leverages its academic expertise and innovative methodologies to investigate and develop novel therapeutic interventions. The university fosters collaboration between researchers, healthcare professionals, and industry partners to ensure rigorous study design, ethical standards, and comprehensive data analysis. By prioritizing scientific excellence and community health, NTNU aims to contribute significantly to the advancement of medical knowledge and the improvement of patient outcomes.

Locations

Taipei, , Taiwan

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported